Diethylcarbamazine overdosage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Diethylcarbamazine}} {{CMG}} <ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Editi...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overdosage== | |||
[[Nausea]], [[vomiting]], [[headache]], [[dizziness]] and [[drowsiness]] are characteristic. In severe cases [[convulsion]]s may occur, requiring treatment with parenteral [[diazepam]]. Treatment is otherwise supportive and symptomatic.<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/3.5.1.html#Jh2922e.3.5.1 | publisher = | date = | accessdate = }}</ref> | |||
<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/3.5.1.html#Jh2922e.3.5.1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 02:14, 7 January 2014
| Diethylcarbamazine |
|---|
| HETRAZAN® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
Nausea, vomiting, headache, dizziness and drowsiness are characteristic. In severe cases convulsions may occur, requiring treatment with parenteral diazepam. Treatment is otherwise supportive and symptomatic.[1]
References
Adapted from the FDA Package Insert.